Security key
45258H106
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 52,769,253
- Total 13F shares
- 2,262,228
- Share change
- -656,214
- Total reported value
- $4,682,595
- Price per share
- $2.07
- Number of holders
- 23
- Value change
- -$1,044,152
- Number of buys
- 10
- Number of sells
- 8
Report period
Q2 2025
Institutions
23
Top holders
10
IMMX full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Immix Biopharma, Inc. SEC filings
Immix Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45258H106
Recent filing periods:
Top shareholders of IMMX - Immix Biopharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bleichroeder LP |
13F
|
Company |
1.6%
|
850,000
|
$1,428,000 | — | 31 Mar 2025 | |
| Cable Car Capital, LP |
13F
|
Company |
1.5%
|
779,358
|
$1,309,321 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.3%
|
698,537
|
$1,173,542 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.3%
|
160,742
|
$270,088 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.18%
|
95,262
|
$160,040 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.16%
|
82,292
|
$138,251 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.1%
|
55,262
|
$92,840 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.08%
|
42,960
|
$72,173 | — | 31 Mar 2025 | |
| Private Advisor Group, LLC |
13F
|
Company |
0.06%
|
31,225
|
$52,458 | — | 31 Mar 2025 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.06%
|
29,300
|
$49,224 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0.03%
|
17,500
|
$29,400 | — | 31 Mar 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.03%
|
17,040
|
$29,000 | — | 31 Mar 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.02%
|
12,833
|
$21,559 | — | 31 Mar 2025 | |
| Focus Partners Wealth |
13F
|
Company |
0.02%
|
11,900
|
$19,992 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.02%
|
11,824
|
$19,864 | — | 31 Mar 2025 | |
| FNY Investment Advisers, LLC |
13F
|
Company |
0.02%
|
11,250
|
$18,000 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
10,121
|
$17,004 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
471
|
$791 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
330
|
$554 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
120
|
$202 | — | 31 Mar 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
80
|
$134 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
35
|
$59 | — | 31 Mar 2025 | |
| Yekaterina Chudnovsky |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
3,274,076
mixed-class rows
|
$6,449,741 | — | 20 Jun 2025 | |
| Sean Senn |
3/4/5
|
Under 10% owner |
—
class O/S missing
|
899,800
|
$4,205,665 | — | 14 Jul 2022 | |
| Vladimir P. Torchilin |
3/4/5
|
Scientific Co-Founder |
—
class O/S missing
|
905,200
|
$4,230,905 | — | 20 Dec 2021 | |
| Carey Ng |
3/4/5
|
Director |
—
mixed-class rows
|
1,078,221
mixed-class rows
|
$2,079,989 | — | 20 Jun 2025 | |
| Jason Hsu |
3/4/5
|
Director |
—
mixed-class rows
|
976,000
mixed-class rows
|
$1,876,570 | — | 20 Jun 2025 | |
| Helen C. Adams |
3/4/5
|
Director |
—
mixed-class rows
|
207,754
mixed-class rows
|
$347,760 | — | 20 Jun 2025 | |
| Magda Marquet |
3/4/5
|
Director |
—
mixed-class rows
|
99,092
mixed-class rows
|
$131,523 | — | 20 Jun 2025 | |
| Jane Buchan |
3/4/5
|
Director |
—
mixed-class rows
|
55,455
mixed-class rows
|
$44,685 | — | 20 Jun 2025 |
Institutional Holders of Immix Biopharma, Inc. - Common Stock (IMMX) as of Q2 2025
As of 30 Jun 2025,
Immix Biopharma, Inc. - Common Stock (IMMX) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,262,228 shares.
The largest 10 holders included
Bleichroeder LP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, NORTHERN TRUST CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, STATE STREET CORP, BlackRock, Inc., Private Advisor Group, LLC, and TOCQUEVILLE ASSET MANAGEMENT L.P..
This page lists
23
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
22
Q2 2025 holders
23
Holder diff
1
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.